SCHOTT PHARMA AG & CO. KGAA SCHOTT Pharma AG & Co. KGaA Share Price Deutsche Boerse AG
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.67 EUR | -4.16% |
|
-14.77% | -7.46% |
| 08:50am | UBS lowers target for Schott Pharma to 33 euros - 'Neutral' | DP |
| 08:24am | SCHOTT PHARMA : UBS reiterates its Neutral rating | ZD |
| Sales 2024 * | 979M 1.06B 83.83B | Sales 2025 * | 1.13B 1.22B 96.44B | Capitalization | 4.75B 5.16B 406B |
|---|---|---|---|---|---|
| Net income 2024 * | 147M 160M 12.58B | Net income 2025 * | 177M 192M 15.15B | EV / Sales 2024 * | 5.05 x |
| Net Debt 2024 * | 201M 219M 17.24B | Net Debt 2025 * | 192M 209M 16.44B | EV / Sales 2025 * | 4.38 x |
| P/E ratio 2024 * |
32
x | P/E ratio 2025 * |
26.6
x | Employees | 4,687 |
| Yield 2024 * |
0.5% | Yield 2025 * |
0.61% | Free-Float | 23% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | -4.16% | ||
| 1 week | -14.77% | ||
| Current month | -22.00% | ||
| 1 month | -19.26% | ||
| 3 months | -17.68% | ||
| 6 months | +12.76% | ||
| Current year | -7.46% |
1 week
31.14
37.20
1 month
31.1440.10
Current year
31.1443.20
1 year
27.4243.20
3 years
27.4243.20
5 years
27.4243.20
10 years
27.4243.20
| Managers | Title | Age | Since |
|---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 30/06/22 |
| Director of Finance/CFO | 43 | 30/06/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 03/04/23 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 03/04/23 |
| Chairman | 59 | 03/04/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/24 | 31.28 | -2.25% | 0 |
| 17/05/24 | 32 | -1.11% | 1,492 |
| 16/05/24 | 32.36 | +1.83% | 398 |
| 15/05/24 | 31.78 | -4.28% | 1,963 |
| 14/05/24 | 33.2 | -9.54% | 1,509 |
Delayed Quote Deutsche Boerse AG, May 20, 2024 at 07:05 am
More quotes
SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.
Calendar
26/06/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
31.52
EUR
Average target price
37.2
EUR
Spread / Average Target
+18.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +6.67% | 42.73B | |
| +25.54% | 32.52B | |
| +20.03% | 26.02B | |
| +1.00% | 25.91B |
- Stock Market
- Equities
- 1SXP Stock
- 1SXP Stock
